NCT07684846
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- UMC Ljubljana Ljubljana, Slovenia
Clinical trial condition
Endocrine Gland Neoplasms
Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.
6,089 public trials
1,370 recruiting studies
Endocrine Gland Neoplasms trial results
Completed
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
NCT00113360
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +17 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT03310632
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Florida Hospital Tampa Tampa, Florida, United States
- Cancer Treatment Centers of America at Southeastern Regional Medical Center Newnan, Georgia, United States
- Henry Ford Health System Detroit, Michigan, United States
- Cancer Treatment Centers of America - Eastern Regional Medical Center Philadelphia, Pennsylvania, United States
NCT01813136
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
- Locations
-
- CHU Angers Angers, France
- CHU Bordeaux Bordeaux, France
- Institut Bergonié Bordeaux, France
- Centre François Baclesse Caen, France
NCT04000880
- Conditions
- Adnexal Diseases, Behavior, Blood Protein Disorders, +67 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Tennessee Health Science Center Memphis, Tennessee, United States
NCT02576431
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +43 more
- Locations
-
- Stanford Cancer Center Palo Alto Palo Alto, California, United States
- UCLA Health Santa Monica Cancer Care Santa Monica, California, United States
- Memorial Cancer Institute at West Pembroke Pines, Florida, United States
- The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
NCT07652450
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +19 more
- Locations
-
- Faculty of medicine Minya, Minya Governorate, Egypt
Completed
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
NCT03239145
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Colonic Diseases, +37 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Completed
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
NCT00183820
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +14 more
- Locations
-
- Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT06713304
- Conditions
- Alcohol Drinking, Alcohol Use, Behavior, +11 more
- Locations
-
- Chulalongkorn University, Faculty of Nursing Bangkok, Thailand